home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

IVERIC bio, Inc. - Common Stock (NQ:ISEE)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 10, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about IVERIC bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 02, 2022

From IVERIC bio, Inc.

Via Business Wire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

December 01, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Iveric Bio Announces Pricing of $300 Million Public Offering of Common Stock

November 30, 2022

From IVERIC bio, Inc.

Via Business Wire

Analyst Ratings for IVERIC bio ↗

November 10, 2022

IVERIC bio (NASDAQ:ISEE) has observed the following analyst ratings within the last quarter:

Via Benzinga

Where IVERIC bio Stands With Analysts ↗

November 10, 2022

IVERIC bio (NASDAQ:ISEE) has observed the following analyst ratings within the last quarter:

Via Benzinga

IVERIC bio, Inc. (ISEE) Q3 2022 Earnings Call Transcript ↗

November 03, 2022

ISEE earnings call for the period ending September 30, 2022.

Via The Motley Fool

Iveric Bio Announces Proposed Offering of Common Stock

November 30, 2022

From IVERIC bio, Inc.

Via Business Wire

How to Trade the High-Growth Biotech Sector in the Midst of a Bear Market ↗

November 23, 2022

Biotech is an exciting and emerging space that’s attracted increasing investor interest in recent years.

Via Benzinga

Foot Locker, Ross Stores, Palo Alto Networks, And Other Big Gainers From Friday ↗

November 21, 2022

U.S. stocks closed higher on Friday, with the Dow Jones gaining around 200 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

IVERIC bio: Q3 Earnings Insights ↗

November 03, 2022

IVERIC bio (NASDAQ:ISEE) reported its Q3 earnings results on Thursday, November 3, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday ↗

November 21, 2022

Gainers AGBA Group Holding Limited (NASDAQ: AGBA) gained 50.7% to close at $6.78 on Friday.

Via Benzinga

Nasdaq Down 0.5%; Clearfield Shares Spike Higher ↗

November 18, 2022

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping over 50 points on Friday.

Via Benzinga

Why Is Iveric Bio (ISEE) Stock Up 25% Today? ↗

November 18, 2022

Biotechnology firm Iveric Bio shot up on a regulatory green light for its key therapeutic, sparking interest in high-risker play ISEE stock.

Via InvestorPlace

Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday's Mid-Day Session ↗

November 18, 2022

Gainers PaxMedica, Inc. (NASDAQ: PXMD) gained 53.5% to $2.38 after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 18, 2022

Via Benzinga

Stocks Brushing Off Latest Fed Fears ↗

November 18, 2022

The Dow Jones Industrial Average is up triple digits midday, while the S&P 500 Index and Nasdaq Composite sit hesitantly higher.

Via Talk Markets

Nasdaq Turns Lower; Crude Oil Down Over 3% ↗

November 18, 2022

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite turning lower on Friday.

Via Benzinga

Dow Surges Over 100 Points; Foot Locker Earnings Top Views ↗

November 18, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Friday.

Via Benzinga

Apellis Pharmaceuticals Surges On New Review Date For Eye-Disease Treatment ↗

November 18, 2022

The delay is at Apellis' behest. The company wanted to include updated data in its request.

Via Investor's Business Daily

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 18, 2022

Via Benzinga

Why Farfetch Shares Are Trading Lower; Here Are 26 Stocks Moving Premarket ↗

November 18, 2022

Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares rose 58.1% to $2.45 in pre-market trading. PaxMedica entered into committed equity investment agreement for up to $20 million with Lincoln Park Capital.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

November 18, 2022

It's time to start closing out the trading week with a dive into the biggest pre-market stock movers for Friday morning!

Via InvestorPlace

IVERIC bio Secures Breakthrough Therapy Tag For Its Flagship Geographic Atrophy Candidate ↗

November 18, 2022

Via Benzinga

Gap, Palo Alto Networks And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

November 18, 2022

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 17, 2022

Via Benzinga

Iveric Bio Announces FDA Has Granted Breakthrough Therapy Designation for Avacincaptad Pegol for Geographic Atrophy

November 17, 2022

From IVERIC bio, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022 ↗

November 10, 2022

Upgrades

Via Benzinga

Iveric Bio to Present at Upcoming Investor Conferences

November 04, 2022

From Iveric Bio

Via Business Wire

Apellis Pharma Crashes On Unexpected Delay For Eye Drug — A Boon For Iveric Bio ↗

November 04, 2022

Apellis long said it wouldn't wait for 24-month data for its eye drug. Apellis was wrong.

Via Investor's Business Daily

Iveric Bio Announces Submission of First Part of NDA for Rolling Review of Avacincaptad Pegol for the Treatment of Geographic Atrophy

November 03, 2022

From IVERIC bio, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com